DK1242105T3 - Præparat af ginseng og ginkgo til forbedring af kognitive funktioner - Google Patents

Præparat af ginseng og ginkgo til forbedring af kognitive funktioner

Info

Publication number
DK1242105T3
DK1242105T3 DK00990685T DK00990685T DK1242105T3 DK 1242105 T3 DK1242105 T3 DK 1242105T3 DK 00990685 T DK00990685 T DK 00990685T DK 00990685 T DK00990685 T DK 00990685T DK 1242105 T3 DK1242105 T3 DK 1242105T3
Authority
DK
Denmark
Prior art keywords
ginseng
cognitive functions
improve cognitive
ginkgo
memory
Prior art date
Application number
DK00990685T
Other languages
English (en)
Other versions
DK1242105T5 (da
Inventor
Orlando Petrini
Andrew Scholey
Original Assignee
Pharmaton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaton Sa filed Critical Pharmaton Sa
Publication of DK1242105T3 publication Critical patent/DK1242105T3/da
Application granted granted Critical
Publication of DK1242105T5 publication Critical patent/DK1242105T5/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00990685T 1999-12-17 2000-12-08 Præparat af ginseng og ginkgo til forbedring af kognitive funktioner DK1242105T5 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17250099P 1999-12-17 1999-12-17
US20835700P 2000-05-31 2000-05-31
PCT/EP2000/012426 WO2001043753A2 (en) 1999-12-17 2000-12-08 Combination of ginseng and ginkgo to improve cognitive skills

Publications (2)

Publication Number Publication Date
DK1242105T3 true DK1242105T3 (da) 2004-05-10
DK1242105T5 DK1242105T5 (da) 2009-12-07

Family

ID=26868153

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00990685T DK1242105T5 (da) 1999-12-17 2000-12-08 Præparat af ginseng og ginkgo til forbedring af kognitive funktioner

Country Status (15)

Country Link
US (2) US20020015744A1 (da)
EP (1) EP1242105B3 (da)
JP (1) JP2003517016A (da)
AT (1) ATE261733T1 (da)
AU (1) AU3008301A (da)
BR (1) BR0016471A (da)
CA (1) CA2394012A1 (da)
DE (1) DE60009145T3 (da)
DK (1) DK1242105T5 (da)
ES (1) ES2213641T7 (da)
MX (1) MXPA02005938A (da)
NZ (1) NZ520210A (da)
PT (1) PT1242105E (da)
TR (1) TR200400577T4 (da)
WO (1) WO2001043753A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10213571A1 (de) * 2002-03-26 2003-10-23 Lichtwer Pharma Ag Pflanzenextrakte und deren Anwendung
WO2004028550A2 (en) * 2002-09-28 2004-04-08 Boehringer Ingelheim International Gmbh Composition comprising panax ginseng and paullinia cupana extracts
CN1305487C (zh) * 2003-03-28 2007-03-21 北京欧纳尔生物工程技术有限公司 治疗良性前列腺增生症引起排尿障碍的药物组合物及其制法
ATE428312T1 (de) * 2004-01-29 2009-05-15 Indena Spa Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung
US10105406B2 (en) 2006-06-05 2018-10-23 Keyview Labs, Inc. Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex
US10105405B2 (en) 2006-06-05 2018-10-23 Keyview Labs, Inc. Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba
DE102008020127A1 (de) * 2008-04-22 2009-11-05 Merz Pharma Gmbh & Co. Kgaa Kompartimentspezifische Pflanzenextraktkombination aus Ginkgo biloba- und Ginseng-Extrakt mit Tandemwirkung
US9956241B2 (en) 2009-05-04 2018-05-01 Naturex, S.A. Application of American Ginseng to enhance neurocognitive function
US20100278944A1 (en) * 2009-05-04 2010-11-04 Naturex, S.A. Application of american ginseng to enhance neurocognitive function
JP5546851B2 (ja) 2009-12-21 2014-07-09 ライオン株式会社 貧血改善剤及び貧血改善用組成物
US10201577B2 (en) 2017-02-14 2019-02-12 Keyview Labs, Inc. Compositions and methods for enhancing working and long-term memory support using new combination of ginkgo biloba and panax ginseng and associated components

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same

Also Published As

Publication number Publication date
EP1242105B1 (en) 2004-03-17
EP1242105A2 (en) 2002-09-25
CA2394012A1 (en) 2001-06-21
AU3008301A (en) 2001-06-25
US6773729B2 (en) 2004-08-10
DE60009145D1 (de) 2004-04-22
US20020015744A1 (en) 2002-02-07
TR200400577T4 (tr) 2004-04-21
WO2001043753A3 (en) 2002-04-25
EP1242105B3 (en) 2009-08-12
DE60009145T2 (de) 2004-07-29
NZ520210A (en) 2004-02-27
JP2003517016A (ja) 2003-05-20
MXPA02005938A (es) 2003-10-14
US20030064118A1 (en) 2003-04-03
ES2213641T3 (es) 2004-09-01
DK1242105T5 (da) 2009-12-07
DE60009145T3 (de) 2010-02-25
BR0016471A (pt) 2002-08-20
ATE261733T1 (de) 2004-04-15
WO2001043753A2 (en) 2001-06-21
PT1242105E (pt) 2004-06-30
ES2213641T7 (es) 2010-03-31

Similar Documents

Publication Publication Date Title
DK1242105T5 (da) Præparat af ginseng og ginkgo til forbedring af kognitive funktioner
CA101100S (en) Pillow
BRPI9902623B1 (pt) composições em pó e em emulsão com vitaminas, comprimido efervescente, bebida e método de produção da composição em pó.
EE05418B1 (et) Diarltskloalklderivaadid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
PT799578E (pt) Preparacao combinada contendo germes enriquecidos com electrolitos
MY148121A (en) Sesamin / episesamin compositions
AU302242S (en) Flashlight
GB2394515B (en) Improvements in rotor blades and/or hydrofoils
MXPA02004933A (es) Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
AU304561S (en) Chair
NO990498D0 (no) 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon
TR200002894T2 (tr) L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon
PL374082A1 (en) Carnitine in the treatment of geriatric depression
ZA977767B (en) Benzylamine derivatives, their preparation and their application in therapeutics.
DE69906680D1 (de) Citronnellyl- und/oder dihydrocitronellyllactate, ihre herstellung und ihre anwendung
ITTO981037A0 (it) Composizione farmaceutica, in particolare di tipo dietetico ad azione metabolica e termogenica utilizzabile nel trattamento del sovrappeso
WO2001085126A3 (en) Cosmetic skin care compositions containing pulegone
CA95630S (en) Cabinet
ATE394943T1 (de) Diätetisches, lösliches, sprudelndes nahrungsergänzungsmittel
GB0218650D0 (en) Cot,two childbeds and chest of drawers combination
CA102676S (en) Cot
HU0401378D0 (en) The use of ph-independent redox potential (rh2) reduced biocolloids in preservation, nutrition, cosmetology and decontanimation
AU128055S (en) Singlet
AU2002342288A1 (en) Utilization of rutins and aescins in the treatment of ocular circulatory disturbances